These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16962375)

  • 1. MHC-peptide specificity and T-cell epitope mapping: where immunotherapy starts.
    Provenzano M; Panelli MC; Mocellin S; Bracci L; Sais G; Stroncek DF; Spagnoli GC; Marincola FM
    Trends Mol Med; 2006 Oct; 12(10):465-72. PubMed ID: 16962375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11.
    Xu Y; Zhu KJ; Chen XZ; Zhao KJ; Lu ZM; Cheng H
    Arch Dermatol Res; 2008 Jun; 300(5):235-42. PubMed ID: 18299861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
    Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
    J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.
    Ulivieri C; Citro A; Ivaldi F; Mascolo D; Ghittoni R; Fanigliulo D; Manca F; Baldari CT; Li Pira G; Del Pozzo G
    Immunol Lett; 2008 Aug; 119(1-2):62-70. PubMed ID: 18538862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
    Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of human leucocyte antigen DQ in the presentation of T cell epitopes in the major cow's milk allergen alphas1-casein.
    Ruiter B; Rozemuller EH; van Dijk AJ; Garssen J; Bruijnzeel-Koomen CA; Tilanus MG; Knol EF; van Hoffen E
    Int Arch Allergy Immunol; 2007; 143(2):119-26. PubMed ID: 17228168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.
    Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentation.
    Denkberg G; Reiter Y
    Autoimmun Rev; 2006 Apr; 5(4):252-7. PubMed ID: 16697965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes.
    Fujiki F; Oka Y; Tsuboi A; Kawakami M; Kawakatsu M; Nakajima H; Elisseeva OA; Harada Y; Ito K; Li Z; Tatsumi N; Sakaguchi N; Fujioka T; Masuda T; Yasukawa M; Udaka K; Kawase I; Oji Y; Sugiyama H
    J Immunother; 2007 Apr; 30(3):282-93. PubMed ID: 17414319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods and protocols for prediction of immunogenic epitopes.
    Tong JC; Tan TW; Ranganathan S
    Brief Bioinform; 2007 Mar; 8(2):96-108. PubMed ID: 17077136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
    Lundberg K; Roos AK; Pavlenko M; Leder C; Wehrum D; Guevara-Patiño J; Andersen RS; Pisa P
    Vaccine; 2009 Mar; 27(10):1557-65. PubMed ID: 19171173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of immobilized HLA-A2:Ig dimeric proteins to determine the level of epitope-specific, HLA-restricted CD8(+) T-cell response.
    Horowitz A; Li X; Poles MA; Tsuji M
    Scand J Immunol; 2009 Nov; 70(5):415-22. PubMed ID: 19874545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin.
    Piesche M; Hildebrandt Y; Zettl F; Chapuy B; Schmitz M; Wulf G; Trümper L; Schroers R
    Hum Immunol; 2007 Jul; 68(7):572-6. PubMed ID: 17584578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen processing is predictable: From genes to T cell epitopes.
    Stevanovic S
    Transpl Immunol; 2005 Aug; 14(3-4):171-4. PubMed ID: 15982559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
    Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
    Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are bacterial vaccine antigens T-cell epitope depleted?
    Halling-Brown M; Sansom CE; Davies M; Titball RW; Moss DS
    Trends Immunol; 2008 Aug; 29(8):374-9. PubMed ID: 18603471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE.
    Bian H; Hammer J
    Methods; 2004 Dec; 34(4):468-75. PubMed ID: 15542373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
    Durántez M; López-Vázquez AB; de Cerio AL; Huarte E; Casares N; Prieto J; Borrás-Cuesta F; Lasarte JJ; Sarobe P
    Scand J Immunol; 2009 Feb; 69(2):80-9. PubMed ID: 19144076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of new cytotoxic T-lymphocyte epitopes from cancer testis antigen HCA587.
    Xing Q; Pang XW; Peng JR; Yin YH; Li Y; Yu X; Zhou SP; Zhang Y; Chen WF
    Biochem Biophys Res Commun; 2008 Jul; 372(2):331-5. PubMed ID: 18498761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetramer-guided epitope mapping reveals broad, individualized repertoires of tetanus toxin-specific CD4+ T cells and suggests HLA-based differences in epitope recognition.
    James EA; Bui J; Berger D; Huston L; Roti M; Kwok WW
    Int Immunol; 2007 Nov; 19(11):1291-301. PubMed ID: 17906339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.